ZEB2 and neoplasm: Interestingly, when the authors introduced a double knockout of Zeb2 and Zeb1 in this same MLL-AF9 model they did not observe any further delay in tumor onset suggesting that Zeb1 loss was could not compound the effect of Zeb2 loss alone.